Csl Ltd has released a press release.
Half Year Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from CSL
- Announcement of buy-back - Appendix 3C
- US FDA Accepts for Review rFVIII BLA
- Update on Novartis Influenza Vaccine Acquisition
- Response to an ASX Query
- Placement
Later from CSL
- IDELVION(R) (rFIX-FP) - CHMP recommendation
- IDELVION(R) (rFIX-FP) - FDA approval
- Changes relating to buy-back - Appendix 3D
- Appendix 4E, FY Results and Analysts Presentation
- Half Yearly Report and Accounts
Follow CSL into a list and get an email when it puts out news.
Follow CSL